國立虎尾科技大學 |

Hereditary Breast and Ovarian Cancer = Molecular Mechanism and Clinical Practice /

Record Type:	Language materials, printed : Monograph/item
Title/Author:	Hereditary Breast and Ovarian Cancer / edited by Seigo Nakamura, Daisuke Aoki, Yoshio Miki.
Reminder of title:	Molecular Mechanism and Clinical Practice /
other author:	Nakamura, Seigo.
Description:	VIII, 324 p. 31 illus., 24 illus. in color.online resource. :
Contained By:	Springer Nature eBook
Subject:	Oncology . -
Online resource:	https://doi.org/10.1007/978-981-16-4521-1
ISBN:	9789811645211

Hereditary Breast and Ovarian Cancer = Molecular Mechanism and Clinical Practice /
Hereditary Breast and Ovarian Cancer Molecular Mechanism and Clinical Practice /[electronic resource] :edited by Seigo Nakamura, Daisuke Aoki, Yoshio Miki. - 1st ed. 2021. - VIII, 324 p. 31 illus., 24 illus. in color.online resource.

1 History, Advancements, and Future Strategies -- 2 Molecular basis of BRCA1 and BRCA2 - Homologous recombination deficiency and tissue-specific carcinogenesis -- 3 Genetic Testing -- 4 Variants of uncertain significances in hereditary breast and ovarian cancer -- 5 Genetic counseling in Hereditary Breast and Ovarian Cancer -- 6 Hereditary Breast Cancer -- 7 Hereditary Ovarian Cancer -- 8 Risk-Based Breast Cancer Screening -- 9 Chemoprevention for Breast Cancer -- 10 Chemoprevention for Ovarian Cancer -- 11 Risk-Reducing Mastectomy (RRM) -- 12 Risk-reducing salpingo-oophorectomy (RRSO) -- 13 Panel Testing -- 14 Germline Findings through Precision Oncology for Ovarian Cancer -- 15 Germline Findings from Genetic Testing for Breast Cancer -- 16 Hereditary Breast and Ovarian Cancer (HBOC) Database -- 17 Ethical Issues: Overview in Genomic analysis and Clinical Context -- 18 PARP Inhibitors-Mechanism of action -- 19 PARPi - Efficacy in Hereditary Breast Cancer -- 20 Efficacy of Poly ADP-Ribose Polymerase Inhibitors for Hereditary Ovarian Cancer.

This highly informative and clearly written book presents the basic science and the latest data on hereditary breast and ovarian cancer (HBOC) to provide an up-to-date and holistic overview of the disease. It starts off by presenting the molecular mechanisms, genetic testing and counseling, and variants of unknown significance (VUS) to help readers understand the contemporary interpretation of the disease. Further chapters focus on the surveillance, diagnosis and treatment, including chemoprevention, risk reduction and drug development based on molecular mechanisms. It also includes a chapter on the latest findings from the HBOC database, ethical issues and the parp inhibitors, and discusses innovative thinking to manage and understand the disease. Hereditary Breast and Ovarian Cancer - Molecular Mechanism and Clinical Practice offers breast surgeons, medical oncologists, gynecological oncologists and genetic counselors a comprehensive overview of the disease. Providing insights into recent scientific findings and further avenues for investigation, it is also a thought-provoking and informative read for researchers and scholars.

ISBN: 9789811645211

Standard No.: 10.1007/978-981-16-4521-1doiSubjects--Topical Terms:

1253469
Oncology .

LC Class. No.: RC254-282

Dewey Class. No.: 616.994

Hereditary Breast and Ovarian Cancer = Molecular Mechanism and Clinical Practice /
LDR:03584nam a22003975i 4500 001 1056445
003 DE-He213
005 20211020123159.0
007 cr nn 008mamaa
008 220103s2021 si | s |||| 0|eng d
020 $a 9789811645211 $9 978-981-16-4521-1
024 7 $a 10.1007/978-981-16-4521-1 $2 doi
035 $a 978-981-16-4521-1
050 4 $a RC254-282
072 7 $a MJCL $2 bicssc
072 7 $a MED062000 $2 bisacsh
072 7 $a MJCL $2 thema
082 0 4 $a 616.994 $2 23
245 1 0 $a Hereditary Breast and Ovarian Cancer $h [electronic resource] : $b Molecular Mechanism and Clinical Practice / $c edited by Seigo Nakamura, Daisuke Aoki, Yoshio Miki.
250 $a 1st ed. 2021.
264 1 $a Singapore : $b Springer Singapore : $b Imprint: Springer, $c 2021.
300 $a VIII, 324 p. 31 illus., 24 illus. in color. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
505 0 $a 1 History, Advancements, and Future Strategies -- 2 Molecular basis of BRCA1 and BRCA2 - Homologous recombination deficiency and tissue-specific carcinogenesis -- 3 Genetic Testing -- 4 Variants of uncertain significances in hereditary breast and ovarian cancer -- 5 Genetic counseling in Hereditary Breast and Ovarian Cancer -- 6 Hereditary Breast Cancer -- 7 Hereditary Ovarian Cancer -- 8 Risk-Based Breast Cancer Screening -- 9 Chemoprevention for Breast Cancer -- 10 Chemoprevention for Ovarian Cancer -- 11 Risk-Reducing Mastectomy (RRM) -- 12 Risk-reducing salpingo-oophorectomy (RRSO) -- 13 Panel Testing -- 14 Germline Findings through Precision Oncology for Ovarian Cancer -- 15 Germline Findings from Genetic Testing for Breast Cancer -- 16 Hereditary Breast and Ovarian Cancer (HBOC) Database -- 17 Ethical Issues: Overview in Genomic analysis and Clinical Context -- 18 PARP Inhibitors-Mechanism of action -- 19 PARPi - Efficacy in Hereditary Breast Cancer -- 20 Efficacy of Poly ADP-Ribose Polymerase Inhibitors for Hereditary Ovarian Cancer.
520 $a This highly informative and clearly written book presents the basic science and the latest data on hereditary breast and ovarian cancer (HBOC) to provide an up-to-date and holistic overview of the disease. It starts off by presenting the molecular mechanisms, genetic testing and counseling, and variants of unknown significance (VUS) to help readers understand the contemporary interpretation of the disease. Further chapters focus on the surveillance, diagnosis and treatment, including chemoprevention, risk reduction and drug development based on molecular mechanisms. It also includes a chapter on the latest findings from the HBOC database, ethical issues and the parp inhibitors, and discusses innovative thinking to manage and understand the disease. Hereditary Breast and Ovarian Cancer - Molecular Mechanism and Clinical Practice offers breast surgeons, medical oncologists, gynecological oncologists and genetic counselors a comprehensive overview of the disease. Providing insights into recent scientific findings and further avenues for investigation, it is also a thought-provoking and informative read for researchers and scholars.
650 0 $a Oncology . $3 1253469
650 0 $a Surgical oncology. $3 1254222
650 0 $a Cancer research. $3 1253664
650 0 $a Human genetics. $3 596505
650 0 $a Molecular biology. $3 583443
650 1 4 $a Oncology. $3 593951
650 2 4 $a Surgical Oncology. $3 673742
650 2 4 $a Cancer Research. $3 668358
650 2 4 $a Human Genetics. $3 593893
650 2 4 $a Molecular Medicine. $3 668353
700 1 $a Nakamura, Seigo. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1361761
700 1 $a Aoki, Daisuke. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1361762
700 1 $a Miki, Yoshio. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1361763
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9789811645204
776 0 8 $i Printed edition: $z 9789811645228
776 0 8 $i Printed edition: $z 9789811645235
856 4 0 $u https://doi.org/10.1007/978-981-16-4521-1
912 $a ZDB-2-SME
912 $a ZDB-2-SXM
950 $a Medicine (SpringerNature-11650)
950 $a Medicine (R0) (SpringerNature-43714)